---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-24-000092"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2024-12-13T23:59:59+00:00"
generated_at: "2026-05-29T03:37:33.609742+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Salarius enters $10M equity purchase agreement with C/M Capital Fund

## Summary
- Up to $10M of common stock may be sold over 36 months at 95% of VWAP or closing price.
- Purchaser C/M Capital Master Fund obligated to buy when Company directs, subject to conditions.
- Exchange Cap of 19.99% of outstanding shares unless stockholder approval or 'at market' exception.
- Company to file registration statement within 30 days covering resale of shares.
- Proceeds for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001615219-24-000092
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2024-12-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521924000092/0001615219-24-000092-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521924000092/flks-20241212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-24-000092
- JSON: https://secwatch.observer/filing/0001615219-24-000092.json
- Plain text: https://secwatch.observer/filing/0001615219-24-000092.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.